“…It has not only broad biological functions such as antitumour, antiviral, antibacterial, interferon-inducing and antifungal activities,1h4 but also various toxic side e †ects such as pyrogenicity, thromobocytopaenia, inhibition of microsomal enzymes, sensitization to endotoxin, liver damage, organomegaly and depression of the reticuloendothelial system.5 Therefore many attempts have been made to obtain a polymeric drug such as DIVEMA with high antitumour activity and low toxicity.6h9 Several studies have also been made in our laboratory to develop polymeric antitumour agents.10h17 However, the synthesis and biological activities of polymers containing the 3,5-dioxo-4,10-dioxatricyclo[5.2.02,6]dec-8-ene (DDTD) moiety have not been reported in the open literature because this monomer dissociates into furan (F) and maleic anhydride (MAH) above 50¡C. 18 The aim of this study was to develop new polymers from DDTD which had good antitumour activity. DDTD was expected to show considerably higher antitumour activity and lower toxicity because its polymer contains cyclic ether and dicarboxylic acid groups some distance from the main chain, in contrast to DIVEMA which has the same groups attached directly to the main chain.…”